10,467 Shares in Intuitive Surgical, Inc. $ISRG Bought by MASTERINVEST Kapitalanlage GmbH

MASTERINVEST Kapitalanlage GmbH purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 2nd quarter, HoldingsChannel reports. The firm purchased 10,467 shares of the medical equipment provider’s stock, valued at approximately $5,688,000.

Other large investors have also recently modified their holdings of the company. Tobam boosted its holdings in Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 40 shares during the period. Kilter Group LLC bought a new stake in Intuitive Surgical in the second quarter valued at approximately $27,000. TD Capital Management LLC lifted its position in Intuitive Surgical by 300.0% in the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 45 shares during the last quarter. 1248 Management LLC purchased a new stake in shares of Intuitive Surgical during the first quarter valued at approximately $30,000. Finally, Princeton Global Asset Management LLC bought a new position in shares of Intuitive Surgical in the second quarter worth approximately $30,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In related news, EVP Brian Edward Miller sold 3,500 shares of Intuitive Surgical stock in a transaction dated Monday, November 10th. The shares were sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the completion of the transaction, the executive vice president directly owned 5,758 shares of the company’s stock, valued at $3,310,850. This trade represents a 37.81% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Craig H. Barratt sold 750 shares of the business’s stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $435,000.00. The disclosure for this sale is available in the SEC filing. Insiders sold 109,043 shares of company stock valued at $60,816,225 over the last 90 days. 0.70% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of equities research analysts recently commented on the stock. Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Intuitive Surgical in a report on Friday, August 22nd. HSBC upped their price objective on shares of Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Daiwa Capital Markets raised their target price on Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a research note on Friday, October 24th. Evercore ISI boosted their price target on Intuitive Surgical from $450.00 to $540.00 in a report on Wednesday, October 22nd. Finally, Truist Financial set a $620.00 price objective on Intuitive Surgical and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Two research analysts have rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $608.79.

Intuitive Surgical Price Performance

ISRG stock opened at $542.32 on Friday. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The firm has a 50-day moving average of $529.62 and a 200 day moving average of $505.69. The company has a market cap of $194.41 billion, a P/E ratio of 71.74, a PEG ratio of 4.98 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. During the same quarter in the prior year, the business earned $1.84 EPS. The business’s revenue for the quarter was up 22.9% on a year-over-year basis. On average, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.